Effects of albuminuria and renal dysfunction on development of dyslipidaemia in type 2 diabetes - The Hong Kong Diabetes Registry

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2834-2840

  Yang, Xilin ^a   So, Wing Yee ^a,b   Ma, Ronald ^a   Ko, Gary ^a   Kong, Alice ^a   Lam, Christopher ^a   Ho, Chung Shun ^a   Cockram, Clive ^a   Chow, Chun Chung ^a   Tong, Peter ^a   Chan, Juliana ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Albuminuria; Chinese; Dyslipidaemia; Hong Kong; Renal function

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ARTICLE; COHORT ANALYSIS; DIABETIC PATIENT; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HONG KONG; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER;

AGED; ALBUMINURIA; CHOLESTEROL; COMORBIDITY; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HONG KONG; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS;

EID: 58549102716     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn149     Document Type: Article

References (21)

1. Shankar A, Klein R, Moss SE et al. The relationship between albuminuria and hypercholesterolemia. J Nephrol 2004; 17: 658-665
2. Ravid M, Brosh D, Ravid-Safran D et al. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia. Arch Intern Med 1998; 158: 998-1004
3. Moorhead JF, Chan MK, El-Nahas M et al. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982; 2: 1309-1311
4. Yang XL, So WY, Kong AP et al. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetologia 2006; 49: 2299-2308
5. Kaysen GA. Dyslipidemia in chronic kidney disease: causes and consequences. Kidney Int 2006; 70: S55-S58
6. Shoji T, Emoto M, Kawagishi T et al. Atherogenic lipoprotein changes in diabetic nephropathy. Atherosclerosis 2001; 156: 425-433
7. Yang X, Ma RC, So WY et al. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry. Cardiovasc Diabetol 2007; 6: 37
8. Piwernetz K, Home PD, Snorgaard O et al. For the DiabCare Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent declaration and the implementation of quality management in diabetes care: the DiabCare initiative. Diab Med 1993; 10: 371-377
9. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944
10. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999; 150: 327-333
11. Harrell F. Regression Modelling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Spinger, 2001
12. So WY, Yang X, Ma RC et al. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes - The Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2008; 24: 238-246
13. Yang X, Kong AP, So WY et al. Effects of chronic hyperglycaemia on incident stroke in Hong Kong Chinese patients with type 2 diabetes. Diabetes Metab Res Rev 2007; 23: 220-226
14. Sarnak MJ, Coronado BE, Greene T et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002; 57: 327-335
15. Parving HH, Lewis JB, Ravid M et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063
16. Genser B, Marz W. Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis. Clin Res Cardiol 2006; 95: 393-404
17. Ko GT, So WY, Chan NN et al. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome. Diab Obes Metab 2006; 8: 94-104
18. de Zeeuw D, Remuzzi G, Parving HH et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921-927
19. Kaysen GA, Eiserich JP. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 2004; 15: 538-548
20. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169
21. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248